Keyphrases
Mouse Model
100%
Tumorigenesis
100%
Colitis-associated Cancer
100%
Erlotinib
100%
Molecular Mechanism
28%
Signaling Pathway
28%
Azoxymethane/dextran Sodium Sulfate
28%
Dysregulated
28%
Inflammatory Bowel Disease
14%
Patient Demographics
14%
Colon
14%
Clinical Setting
14%
Cancer Development
14%
Wnt Signaling
14%
Antitumor Agents
14%
Small Molecule Inhibitors
14%
Premixed
14%
Polyps
14%
Gene Alteration
14%
Epidermal Growth Factor Receptor
14%
Aggressive Behavior
14%
Significant Genes
14%
Antitumor Efficacy
14%
Sporadic Colorectal Cancer
14%
Epidermal Growth Factor Receptor Signaling
14%
Repurposing
14%
Parts per Million
14%
Hippo Pathway
14%
Tumor multiplicity
14%
KEGG Enrichment Analysis
14%
AIN-93
14%
Bulk RNA Sequencing
14%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Mouse Model
100%
Carcinogenesis
100%
Colitis
100%
Erlotinib
100%
Dextran Sulfate
28%
Azoxymethane
28%
Epidermal Growth Factor Receptor
28%
Colorectal Carcinoma
14%
Neoplasm
14%
Anticarcinogen
14%
Inflammatory Bowel Disease
14%
Polyp
14%
RNA-Sequencing
14%
Biochemistry, Genetics and Molecular Biology
Mouse Model
100%
Carcinogenesis
100%
Erlotinib
100%
Dextran
40%
Sodium Sulfate
40%
Epidermal Growth Factor Receptor
40%
Colon
20%
Small Molecule
20%
Gene Mutation
20%
Wnt Signaling Pathway
20%
Hippo Signaling Pathway
20%
Bulk RNA Sequencing
20%